Short Interest in ReShape Lifesciences Inc. (NASDAQ:RSLS) Decreases By 38.1%

ReShape Lifesciences Inc. (NASDAQ:RSLS) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 18,500 shares, a drop of 38.1% from the December 15th total of 29,900 shares. Approximately 2.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 84,300 shares, the short-interest ratio is presently 0.2 days.

ReShape Lifesciences Price Performance

Shares of RSLS stock traded down $0.34 during midday trading on Tuesday, reaching $4.66. 42,334 shares of the company traded hands, compared to its average volume of 31,639. The firm’s 50 day simple moving average is $5.05 and its two-hundred day simple moving average is $7.57. ReShape Lifesciences has a 1-year low of $4.09 and a 1-year high of $29.00.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.